Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20625206 | 0.86 | HPGD (0.44) | HPGDALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL1015504 | 0.80 | HPGD (0.48) | HPGDALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL1016103 | 0.80 | HPGD (0.48) | HPGDALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL1015503 | 0.80 | HPGD (0.48) | HPGDALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL27530374 | 0.77 | HPGD (0.49) | HPGDALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL2200874 | 0.77 | HPGD (0.49) | HPGDALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL20599594 | 0.76 | HPGD (0.45) | HPGDALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL3862180 | 0.73 | HPGD (0.45) | HPGDALDH1A1KMT2AMEN1KDM4E | |
| SCHEMBL7904840 | 0.71 | HPGD (0.44) | HPGDALDH1A1KMT2AMEN1KDM4E | |
| SCHEMBL22076454 | 0.71 | HPGD (0.41) | HPGDALDH1A1KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9829487-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2017-11-28 | — | — | US | disclosed |
| US-9079835-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2015-07-14 | — | — | US | disclosed |
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | NATIONAL SCIENCE FOUNDATION | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | SPR, SAMSN1, NAPA | HPGD 3895/4885ALDH1A1 2389/4885KMT2A 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.